372. Co-Administration of OVX836, NP-Based Universal Influenza Vaccine Candidate, with Conventional HA-Based Influenza Vaccine: Results of Phase 2a Clinical trial

BACKGROUND: Quadrivalent Inactivated Influenza Vaccine (QIV) generate antibody responses mostly directed against the highly mutating hemagglutinin. An alternative path for influenza vaccination is to generate cellular immunity to well-conserved nucleoprotein (NP), which has been associated with prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Willems, Paul, Tourneur, Jessika, Guyon-Gellin, Delphine, Le Vert, Alexandre, Nicolas, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678219/
http://dx.doi.org/10.1093/ofid/ofad500.442

Ejemplares similares

Ejemplares similares